Neuromuscular Blockade Monitoring Using Kine-myography vs Electromyography.

Sponsor
Masarykova Nemocnice v Usti nad Labem, Krajska Zdravotni a.s. (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05992090
Collaborator
(none)
180
1
14.4
12.5

Study Details

Study Description

Brief Summary

This study aims to compare two monitoring methods of neuromuscular blockade - Kine-myography and Electromyography.

The main questions to answer are:
  • are electromyography and kine-myography interchangeable

  • is electromyography linked to fewer fault results

  • is electromyography using lower energy to stimulate nerves

The type of study is a multicentric observational clinical trial. Subjects are patients undergoing general anaesthesia with the use of rocuronium or cis-atracurium. In each patient, the neuromuscular blockade will be monitored using kine-myograph and electromyography simultaneously.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    Informed consent will first be obtained from the patient for inclusion in the study. Consent will be obtained during an examination by the anaesthesiologist providing anaesthetic care during surgery in the anteroom of the operating theatre.

    Once informed consent has been obtained, a routine orientation examination will be performed by the anaesthetist and routine pre-operative preparation (provision of peripheral venous access, risk assessment for airway obstruction, etc.) will be performed. The patient will then be transported to the operating theatre.

    In the operating room, patient monitoring will be initiated, including the deployment of sensors to monitor the depth of neuromuscular blockade. The KMG sensor will be placed on the right arm and the EMG sensor on the left arm. After deployment of the sensors, upper limb fixation will be performed by the anaesthetic nurse. The fixation will be performed with splints compatible with the operating table. Fixation of the limbs and sensor with adhesive tape will not be used.

    The anaesthesia will then be induced. Propofol and sufentanil will be administered at the discretion of the anaesthetist providing anaesthetic care. Once sufficient depth of sedation has been induced, calibration of the sensors monitoring the depth of neuromuscular blockade will be performed. After calibration of the sensors, the supramaximal current to the CRF will be recorded. The measurement interval will be set to 20 s. After securing the airway, the interval will be extended to 5 - 15 min according to the nature of the surgery and the discretion of the anaesthesiologist providing anaesthetic care. The number of twitches (PCT) and the Train Of Four (TOF) value will be recorded throughout the procedure.

    On emergence from anaesthesia, the measurement interval will be set to 1 minute. Once sufficient depth of neuromuscular blockade has been reached to allow extubation, monitoring of the depth of neuromuscular blockade will be discontinued.

    If during the measurement of the depth of neuromuscular blockade a value is measured that is highly suspected to be in error, this suspicion will be recorded in the CRF with a justification.

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    180 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Official Title:
    Neuromuscular Blockade Monitoring Using Kine-myography vs Electromyography in Patients Undergoing General Anaesthesia With the Use of Rocuronium and Cis-atracurium.
    Anticipated Study Start Date :
    Sep 30, 2023
    Anticipated Primary Completion Date :
    Mar 30, 2024
    Anticipated Study Completion Date :
    Dec 10, 2024

    Outcome Measures

    Primary Outcome Measures

    1. Measurement variability [From sensor calibration til extubation at TOF higher than 90%.Maximum length of measurement is 6 hours.]

      A primary aim is to demonstrate that measurement of the depth of neuromuscular blockade using kinemyography is associated with a higher measurement variability than measurement of the depth of neuromuscular blockade using electromyography.

    Secondary Outcome Measures

    1. supramaximal electric stimulus [From sensor calibration til extubation at TOF higher than 90%.Maximum length of measurement is 6 hours.]

      A secondary aim is to demonstrate that measuring the depth of neuromuscular blockade using kinemyography is associated with a higher supramaximal electric stimulus than measuring the depth of neuromuscular blockade using electromyography.

    2. TOF overestimation [From sensor calibration til extubation at TOF higher than 90%.Maximum length of measurement is 6 hours.]

      The primary objective of the study is to demonstrate that there is measured higher TOF when using KMG to monitor the depth of neuromuscular blockade compared to using EMG sensor to monitor the depth of neuromuscular blockade.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    N/A and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • patients undergoing surgery under general anaesthesia with the use of cis-atracurium or rocuronium
    Exclusion Criteria:
    • patients suffering from neuromuscular diseases

    • patients with known allergy to rocuronium or cis-atracurium

    • patients in whom it is impossible to measure the depth of the neuromuscular block on the upper extremities (injuries of the upper extremities, contractures etc.)

    • patients undergoing surgery positioned on their side

    • patients with an upper arm injury

    • patients with acromegaly

    • patients with Alzheimer's disease

    • patients with the risk of difficult airways

    • patients induced into general anaesthesia via the Rapid Sequence Induction method

    • patients with a weight under 5 kilograms

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Masarykova Nemocnice v Ústí nad Labem, Krajská Zdravotní a.s. Ústí Nad Labem Ústí Nad Labem Region Czechia 40001

    Sponsors and Collaborators

    • Masarykova Nemocnice v Usti nad Labem, Krajska Zdravotni a.s.

    Investigators

    • Principal Investigator: Michal Kalina, MUDr., Krajská Zdravotní a.s., Masarykova Nemocnice v Ústí nad Labem, Klinika anesteziologie, perioperační a intenzivní medicíny FZS UJEP a MNUL

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Michal Kalina, principal investigator, Masarykova Nemocnice v Usti nad Labem, Krajska Zdravotni a.s.
    ClinicalTrials.gov Identifier:
    NCT05992090
    Other Study ID Numbers:
    • EMG vs KMG
    First Posted:
    Aug 15, 2023
    Last Update Posted:
    Aug 15, 2023
    Last Verified:
    Aug 1, 2023
    Individual Participant Data (IPD) Sharing Statement:
    Undecided
    Plan to Share IPD:
    Undecided
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Michal Kalina, principal investigator, Masarykova Nemocnice v Usti nad Labem, Krajska Zdravotni a.s.
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Aug 15, 2023